Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D2.366 - The establishment of a Japanese cypress pollen environmental exposure chamber protocol
D2.367 - Omalizumab Efficacy in Relapse of Nasal Polyposis
D2.368 - Lack of anaerobic gut bacteria in patients with aspirin intolerance and allergy
D2.369 - Impaired Retinoic Acid Metabolism and Eotaxin Overexpression in Eosinophilic Chronic Rhinosinusitis: Insights into Pathophysiology and Therapeutic Potential of CRABP1 Targeting
D2.370 - Trends in Sensitization to Pet Allergens and Correlation between Symptoms and Asthma in Allergic Rhinitis from 2017 to 2023 in China
D2.372 - Evaluating ChatGPT's Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
D2.374 - Smoking increases mortality risk of chronic inflammatory airway diseases: a real-world hospital cohort study
D2.375 - Concomitant allergic and ENT pathology in children with chronic inflammatory diseases
D2.376 - The role of endoscopic sinus surgery in chronic rhinosinusitis with minimally affected computed tomography
D2.378 - Exploring the Connection Between Allergic Rhinitis and Sinusitis in Children
D2.371 - Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps
D2.373 - Diurnal variation in Japanese cedar pollinosis symptoms
D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report
D3.268 - Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production
D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings
D3.270 - A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system
D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria
D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria
D3.275 - Anaphylaxis caused by polyhexanide
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download